NeonMind Biosciences EBITDA vs. Current Ratio

NMDBFDelisted Stock  USD 0.50  0.00  0.00%   
Based on NeonMind Biosciences' profitability indicators, NeonMind Biosciences may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess NeonMind Biosciences' ability to earn profits and add value for shareholders.
For NeonMind Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NeonMind Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NeonMind Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NeonMind Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NeonMind Biosciences over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Please note, there is a significant difference between NeonMind Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeonMind Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeonMind Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

NeonMind Biosciences Current Ratio vs. EBITDA Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining NeonMind Biosciences's current stock value. Our valuation model uses many indicators to compare NeonMind Biosciences value to that of its competitors to determine the firm's financial worth.
NeonMind Biosciences is considered to be number one stock in ebitda category among its peers. It also is considered to be number one stock in current ratio category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NeonMind Biosciences' earnings, one of the primary drivers of an investment's value.

NeonMind Current Ratio vs. EBITDA

EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

NeonMind Biosciences

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(6.65 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

NeonMind Biosciences

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
0.59 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

NeonMind Current Ratio Comparison

NeonMind Biosciences is currently under evaluation in current ratio category among its peers.

NeonMind Biosciences Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in NeonMind Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NeonMind Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of NeonMind Biosciences' change in net profit over the period of time. It can combine multiple indicators of NeonMind Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp. Neonmind Biosciences is traded on OTC Exchange in the United States.

NeonMind Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on NeonMind Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NeonMind Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NeonMind Biosciences' important profitability drivers and their relationship over time.

Use NeonMind Biosciences in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeonMind Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeonMind Biosciences will appreciate offsetting losses from the drop in the long position's value.

NeonMind Biosciences Pair Trading

NeonMind Biosciences Pair Trading Analysis

The ability to find closely correlated positions to NeonMind Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeonMind Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeonMind Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeonMind Biosciences to buy it.
The correlation of NeonMind Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeonMind Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeonMind Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeonMind Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your NeonMind Biosciences position

In addition to having NeonMind Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Heavy Metals Thematic Idea Now

Heavy Metals
Heavy Metals Theme
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in NeonMind Pink Sheet

If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules